Skip to content
Menu

Century Therapeutics, Inc. IPSC

Full chart Compare
Set alert

Price alert · IPSC

All alert types
1.19 USD -0.13 (-9.85%)

As ofNov 20, 2026, 12:05 PM EST

1.18 Day range 1.32
0.464 52-week range 3.04
YTD
+19.60%
1 year
+142.36%

Analyst view

Consensus: buy

Buy
Price target (mean) 9.67 +712.3% upside
Target (low)
5.00
Target (mean)
9.67
Target (high)
12.00
Ratings (0m) 7 6 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy4
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 7
  • 1 month ago 7

Included in Essentials and up

Sign in to see Revenue and earnings forecast

Reported revenue and earnings per share by year, then what analysts expect next.

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

IPSC analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.4375-0.47 – -0.41-0.4577+4.4%975.00K+263.8%4
Next quarter-0.4425-0.46 – -0.42-0.45+1.7%633.33K-25.9%4
Current year-1.59-1.66 – -1.45-2.03+21.6%3.29M+47.2%5
Next year-1.83-1.98 – -1.63-1.59-15.0%3.77M+14.5%5

Upgrades and downgrades

The latest rating changes

IPSC analyst upgrades and downgrades
DateFirmActionFromTo
Nov 7, 2024Chardan CapitalMaintainedBuyBuy
Nov 6, 2024HC Wainwright & Co.MaintainedBuyBuy
Aug 15, 2024HC Wainwright & Co.MaintainedBuyBuy
Jun 17, 2024Piper SandlerMaintainedOverweightOverweight
Jun 4, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 10, 2024HC Wainwright & Co.MaintainedBuyBuy
Apr 12, 2024Piper SandlerReiteratedOverweightOverweight
Mar 15, 2024Canaccord GenuityMaintainedBuyBuy
Mar 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Dec 7, 2023HC Wainwright & Co.ReiteratedBuyBuy
Aug 28, 2023JP MorganDowngradeOverweightNeutral
Aug 10, 2023Piper SandlerMaintainedOverweightOverweight
Aug 10, 2023HC Wainwright & Co.MaintainedBuyBuy
Aug 10, 2023EF HuttonReiteratedBuyBuy
Aug 10, 2023Chardan CapitalMaintainedBuyBuy
May 12, 2023HC Wainwright & Co.ReiteratedBuyBuy
Apr 17, 2023EF HuttonMaintained—Buy
Apr 13, 2023HC Wainwright & Co.Reiterated—Buy
Mar 22, 2023Chardan CapitalReiterated—Buy
Mar 17, 2023HC Wainwright & Co.Maintained—Buy
Mar 16, 2023EF HuttonReiterated—Buy
Feb 9, 2023HC Wainwright & Co.Reiterated—Buy
Jan 6, 2023EF HuttonMaintained—Buy
Jan 6, 2023SVB LeerinkMaintained—Outperform
Jan 6, 2023Piper SandlerMaintained—Overweight
Jan 6, 2023HC Wainwright & Co.Maintained—Buy
Jan 5, 2023EF HuttonInitiated—Buy
Dec 27, 2022Chardan CapitalInitiated—Buy
Nov 14, 2022HC Wainwright & Co.Maintained—Buy
Oct 31, 2022GuggenheimInitiated—Buy

Included in Plus and up

Sign in to see Analyst trend

Two years of the analyst rating mix and the average price target against the price.